Dirk Wuttge
1 – 50 of 52
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
- 2023
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
-
Mark
Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis
(
- Contribution to journal › Article
- 2022
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
(
- Contribution to journal › Article
- 2020
-
Mark
Pulmonary arterial hypertension in systemic sclerosis - When criteria and pathobiology differ
(
- Contribution to journal › Letter
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Type III, IV, and VI Collagens Turnover in Systemic Sclerosis – a Longitudinal Study
(
- Contribution to journal › Article
-
Mark
Successful lung transplantation in a patient with rheumatoid arthritis suffering from obliterative bronchiolitis
(
- Contribution to journal › Letter
- 2019
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(
- Contribution to journal › Letter
- 2018
-
Mark
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
(
- Contribution to journal › Article
-
Mark
Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis : A magnetic resonance study
(
- Contribution to journal › Article
- 2016
-
Mark
CD81 and CD48 show different expression on blood eosinophils in systemic sclerosis: new markers for disease and pulmonary inflammation?
(
- Contribution to journal › Article
-
Mark
The modified hand mobility in scleroderma test and skin involvement - A followup study
(
- Contribution to journal › Article
-
Mark
Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjögren's syndrome and systemic sclerosis
(
- Contribution to journal › Article
- 2015
-
Mark
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
(
- Contribution to journal › Article
-
Mark
Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Airway resistance and reactance are affected in systemic sclerosis.
(
- Contribution to journal › Article
- 2014
-
Mark
Development of a Modified Hand Mobility in Scleroderma (HAMIS) Test and its Potential as an Outcome Measure in Systemic Sclerosis.
(
- Contribution to journal › Article
- 2013
-
Mark
Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals - a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes
(
- Contribution to journal › Article
-
Mark
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
(
- Contribution to journal › Article
-
Mark
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
(
- Contribution to journal › Article
- 2012
-
Mark
Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods
(
- Contribution to journal › Article
-
Mark
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
(
- Contribution to journal › Article
-
Mark
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
(
- Contribution to journal › Article
- 2011
-
Mark
The Functional Polymorphism 844 A>G in Fc{alpha}RI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility.
(
- Contribution to journal › Article
-
Mark
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult
(
- Contribution to journal › Article
-
Mark
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease
(
- Contribution to journal › Article
-
Mark
Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.
(
- Contribution to journal › Article
-
Mark
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations.
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Expression of activation markers on eosinophils in patients with systemic sclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Interleukin-15 attenuates transforming growth factor-beta1-induced myofibroblast differentiation in human fetal lung fibroblasts.
(
- Contribution to journal › Article
-
Mark
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).
(
- Contribution to journal › Article
-
Mark
Increased alveolar nitric oxide in early systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients.
(
- Contribution to journal › Article
- 2009
-
Mark
The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Distinct Temporal Evolution of TLR-mediated Dendritic Cell Cytokine Secretion in Patients with Limitied and Diffuse Cutaneous Systemic Sclerosis
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.153-154(
- Contribution to journal › Published meeting abstract
-
Mark
Renal function is mostly preserved in patients with systemic sclerosis.
(
- Contribution to journal › Article
- 2007
-
Mark
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
(
- Contribution to journal › Article
-
Mark
Antibody microarray-based serum protein profiling of system lupus erythematosus and systemic sclerosis
2007) American College of Rheumatology (ACR) meeting In Proceedings of the American College of Rheumatology (ACR) meeting(
- Contribution to journal › Published meeting abstract
-
Mark
Antibody microarray-based serum protein profiling of systemic lupus erythematosus and systemic sclerosis
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions
(
- Contribution to journal › Article
- 2002
-
Mark
Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice
(
- Contribution to journal › Article
- 2001
-
Mark
Expression of interleukin-15 in mouse and human atherosclerotic lesions
(
- Contribution to journal › Article
-
Mark
Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis
(
- Contribution to journal › Article
-
Mark
Gene expression in atherosclerotic lesion of ApoE deficient mice
(
- Contribution to journal › Article
- 1999
-
Mark
T-cell recognition of lipid peroxidation products breaks tolerance to self proteins
(
- Contribution to journal › Article